We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISO
1301
DELISTED
IsoPlexis Corporation Common Stock
ISO
$38K ﹤0.01%
+17,464
New +$40.6K
APRE icon
1302
Aprea Therapeutics
APRE
$7.94M
$33K ﹤0.01%
2,250
-750
-25% -$17.3K
ESOA icon
1303
Energy Services of America
ESOA
$293M
$31K ﹤0.01%
+15,000
New +$37K
MDIA icon
1304
Mediaco Holding
MDIA
$83.1M
$27K ﹤0.01%
12,992
– –
ALLR
1305
Allarity Therapeutics
ALLR
$22M
– –
0
– –
MITQ icon
1306
Moving iMage Technologies
MITQ
$5.27M
$26K ﹤0.01%
+20,300
New +$24K
SYRE icon
1307
Spyre Therapeutics
SYRE
$9.02B
$25K ﹤0.01%
1,946
-2,974
-60% -$104K
LOGC
1308
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$25K ﹤0.01%
69,900
-10,000
-13% -$5.06K
EAR
1309
DELISTED
Eargo, Inc. Common Stock
EAR
$23K ﹤0.01%
1,500
– –
RHE
1310
DELISTED
Regional Health Properties, Inc.
RHE
$23K ﹤0.01%
+10,000
New +$27.5K
ARAV
1311
DELISTED
Aravive, Inc. Common Stock
ARAV
$22K ﹤0.01%
22,625
-35,000
-61% -$46.2K
SCOR icon
1312
Comscore
SCOR
$112M
$21K ﹤0.01%
515
-11,355
-96% -$472K
CRXT
1313
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$17K ﹤0.01%
45,000
-45,000
-50% -$31.5K
CRIS icon
1314
Curis
CRIS
$8.44M
$16K ﹤0.01%
+42
New +$17.5K
FNHC
1315
DELISTED
FedNat Holding Company Common Stock
FNHC
$16K ﹤0.01%
51,300
– –
LGL.WS
1316
DELISTED
LGL Group Inc Warrants
LGL.WS
$14K ﹤0.01%
29,200
– –
SCPS
1317
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$14K ﹤0.01%
32,966
-35,000
-51% -$16.8K
CBUS icon
1318
Cibus
CBUS
$141M
$11K ﹤0.01%
879
-2,057
-70% -$43.3K
ERNA icon
1319
Eterna Therapeutics
ERNA
$5.03M
$7K ﹤0.01%
2
-16
-89% -$115K
CFMS
1320
DELISTED
Conformis, Inc. Common Stock
CFMS
$6K ﹤0.01%
640
– –
ADNT icon
1321
Adient
ADNT
$1.51B
– –
-65,050
Closed -$2.65M
AHT
1322
Ashford Hospitality Trust
AHT
$20.7M
– –
-56,860
Closed -$5.8M
ALLK
1323
DELISTED
Allakos
ALLK
– –
-47,600
Closed -$271K
ARDX icon
1324
Ardelyx
ARDX
$1.22B
– –
-100,000
Closed -$107K
ATI icon
1325
ATI
ATI
$31B
– –
-84,037
Closed -$2.26M
51 52
53
54 55

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.